Selected Cell
Cell:
Value:
BAC
NHP
PAV
TIS
AB
ABP
D.FCS
D.FLOW
A.FLOW
D.CYTOF
A.CYTOF
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | Name | Scientist | Notes | Publish_uri | Species | Morphology | Strain | TaxonomyID | |
| BAC-241002NIH-1 | BCG Danish Strain 1331 | NIH | Danish Statens Serum Institut BCG SSI Strain 1331 | https://fairdomhub.org/samples/54806, https://fairdomhub.org/samples/59086 | Mycobacterium tuberculosis variant bovis BCG | Bacillus | Danish SSI 1331 | 33892 | |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
| UID | Name | DateOfBirth | Sex | Species | Origin | Facility | Scientist | Cohort | Protocol |
| NHP-220830FLY-3 | 4119 | 2013-01-01 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-4 | 4219 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | IgG | https://fairdomhub.org/sops/809 | |
| NHP-220830FLY-5 | 4319 | 2013-01-01 00:00:00 | F | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | IgG | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-7 | 4519 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | IgG | https://fairdomhub.org/sops/809 | |
| NHP-220830FLY-10 | 4819 | F | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 | |
| NHP-220830FLY-14 | 5219 | 2012-04-01 00:00:00 | F | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-34 | 9621 | 2017-05-15 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-40 | 10221 | 2017-06-09 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-44 | 19521 | 2017-04-16 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-51 | 20221 | 2017-04-02 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-59 | 21219 | 2015-01-01 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-62 | 21519 | 2015-01-01 00:00:00 | F | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | IgG | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-65 | 21819 | 2015-05-02 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-66 | 21919 | 2015-01-01 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | Saline | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-68 | 22119 | 2014-07-04 00:00:00 | F | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | IgG | https://fairdomhub.org/sops/809 |
| NHP-220830FLY-73 | 22619 | 2015-05-10 00:00:00 | M | Macaca mulatta (Rhesus) | India | Flynn Lab | JoAnne Flynn | IgG | https://fairdomhub.org/sops/809 |
| NHP-220913SED-16 | SEDXX1 | Macaca mulatta | India | Seder Lab | Robert Seder | 2-IV BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-17 | SEDXX2 | Macaca mulatta | India | Seder Lab | Robert Seder | 2-IV BCG | https://fairdomhub.org/sops/809 | ||
| NHP-221019SED-1 | SEDXX5 | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |||
| NHP-221019SED-2 | SEDXX6 | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |||
| NHP-240821SED-1 | SEDXX8 | F | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | ||
| NHP-240821SED-2 | SEDXX10 | 2017-05-15 00:00:00 | F | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-3 | SEDXX11 | 2018-05-16 00:00:00 | F | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-4 | SEDXX12 | 2020-05-25 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-5 | SEDXX13 | 2020-05-05 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-6 | SEDXX14 | 2021-01-01 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-7 | SEDXX15 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | ||
| NHP-240821SED-8 | SEDXX16 | 2016-03-23 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-9 | SEDXX17 | 2018-04-22 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-10 | SEDXX18 | 2021-01-01 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-11 | SEDXX19 | 2020-01-01 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-12 | SEDXX20 | 2020-01-01 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-13 | SEDXX21 | 2020-06-22 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-14 | SEDXX22 | 2019-01-01 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-240821SED-15 | SEDXX23 | 2021-01-01 00:00:00 | M | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |
| NHP-220830FLY-39 | 10121 | M | Macaca mulatta | India | Flynn Lab | JoAnne Flynn | https://fairdomhub.org/sops/809 | ||
| NHP-220830FLY-22 | 8421 | M | Macaca mulatta | India | Flynn Lab | JoAnne Flynn | https://fairdomhub.org/sops/809 | ||
| NHP-220830FLY-23 | 8521 | M | Macaca mulatta | India | Flynn Lab | JoAnne Flynn | https://fairdomhub.org/sops/809 | ||
| NHP-220830FLY-50 | 20121 | M | Macaca mulatta | India | Flynn Lab | JoAnne Flynn | https://fairdomhub.org/sops/809 | ||
| NHP-220830FLY-55 | 20621 | M | Macaca mulatta | India | Flynn Lab | JoAnne Flynn | https://fairdomhub.org/sops/809 | ||
| NHP-221019SED-3 | SEDXX7 | Macaca mulatta | India | Seder Lab | Robert Seder | https://fairdomhub.org/sops/809 | |||
| NHP-220913SED-1 | IVBCGXX1 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Intradermal BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-2 | IVBCGXX2 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-IV BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-3 | IVBCGXX3 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Aerosol BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-4 | IVBCGXX4 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Intradermal BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-5 | IVBCGXX5 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Intradermal BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-6 | IVBCGXX6 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-IV BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-7 | IVBCGXX7 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Aerosol BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-8 | IVBCGXX8 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Intradermal BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-9 | IVBCGXX9 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Intradermal BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-10 | IVBCGX10 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-IV BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-11 | IVBCGX11 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Aerosol BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-12 | IVBCGX12 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Intradermal BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-13 | IVBCGX13 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Naive | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-14 | IVBCGX14 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Naive | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-15 | IVBCGX15 | Macaca mulatta | India | Seder Lab | Robert Seder | 1-Naive | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-18 | SEDXX3 | Macaca mulatta | India | Seder Lab | Robert Seder | 2-IV BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913SED-19 | SEDXX4 | Macaca mulatta | India | Seder Lab | Robert Seder | 2-IV BCG | https://fairdomhub.org/sops/809 | ||
| NHP-220913FLY-1 | 17819 | 2014-01-14 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-2 | 17919 | 2014-01-01 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-3 | 18619 | 2015-01-01 00:00:00 | Female | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-4 | 18719 | 2015-01-01 00:00:00 | Female | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-5 | 18119 | 2015-01-01 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-6 | 18419 | 2015-05-11 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-7 | 18519 | 2015-01-01 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-8 | 18219 | 2015-01-15 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-9 | 18019 | 2015-01-01 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-IV BCG | https://fairdomhub.org/sops/809 |
| NHP-220913FLY-10 | 18319 | 2015-01-15 00:00:00 | Male | Macaca mulatta | Indian | Flynn Lab | JoAnne Flynn | 2-Naive | https://fairdomhub.org/sops/809 |
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
AA
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
| UID | Name | Notes | Scientist | Publish_uri | Treatment1 | Treatment1Type | Treatment1Route | Treatment1Dose | Treatment1DoseUnits | Treatment1Parent | Treatment2 | Treatment2Type | Treatment2Route | Treatment2Dose | Treatment2DoseUnits | Treatment3 | Treatment3Type | Type | ScanID | Procedure | Parent | VisitFacility | SampleCreationDate | Treatment3Route | Treatment3Dose | Treatment3DoseUnits | Treatment4 | Treatment4Type | Treatment4Route | Treatment4Dose | Treatment4DoseUnits | Treatment5 | Treatment5Type | Treatment5Route | Treatment5Dose | Treatment5DoseUnits | ExperimentalTimepoint |
| PAV-220830FLY-17 | 10121-201116 | Administered at vendor. | JoAnne Flynn | https://fairdomhub.org/samples/59178 | BCG inoculation | Vaccination | Intravenously | 2 | milliliter | BAC-241002NIH-1 | Treatment; Blood; Tissue Extraction | NHP-220830FLY-39 | VRC (NIH) | 2020-11-16 00:00:00 | |||||||||||||||||||||||
| PAV-220830FLY-18 | 10121-210322 | 1st strongyloides treatment. | JoAnne Flynn | https://fairdomhub.org/samples/59179 | Pyrantel | Medication | Orally | 51.7 | milligram | Treatment | NHP-220830FLY-39 | Flynn Lab | 2021-03-22 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-19 | 10121-210329 | 2nd strongyloides treatment. | JoAnne Flynn | https://fairdomhub.org/samples/59180 | Pyrantel | Medication | Orally | 51.7 | milligram | Treatment | NHP-220830FLY-39 | Flynn Lab | 2021-03-29 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-20 | 10121-210412 | 3rd strongyloides treatment. | JoAnne Flynn | https://fairdomhub.org/samples/59181 | Pyrantel | Medication | Orally | 51.7 | milligram | Treatment | NHP-220830FLY-39 | Flynn Lab | 2021-04-12 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-21 | 10121-210505 | Infusion premed administered 30 minutes prior to infusion at 8;45 am. , LN Bx, Infusion premed administered 30 minutes prior to infusion at 8;45 am., Pre-dosing vitals; HR 166, RR 60, T 99.9. Interim vitals; HR 160, RR 66, T 99.1. End of infusion vitals; HR 163, RR 60, T 99.3. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59182 | Acetaminophen | Medication | Orally | 80 | milligram | Banamine | Medication | Intramuscularly | 9.4 | milligram | Diphenhydramine | Medication | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-39 | Flynn Lab | 2021-05-05 00:00:00 | Orally | 6 | milligram | Saline | Control | Intravenously | 50 | milliliter | ||||||||
| PAV-220830FLY-22 | 10121-210520 | Infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR148, RR30, T 100.5. Interim vitals; HR152, RR30, T 100.2, End of infusion vitals; HR 157, RR44, T100.1. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59183 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 5 | milligram | Saline | Control | Blood; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-39 | Flynn Lab | 2021-05-20 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-23 | 10121-210527 | LN Bx | JoAnne Flynn | https://fairdomhub.org/samples/59184 | Banamine | Medication | Intramuscularly | 8.8 | milligram | Tissue Extraction; Treatment | NHP-220830FLY-39 | Flynn Lab | 2021-05-27 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-24 | 10121-210602 | Infusion premed administered 30 minutes prior to infusion., infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR193, RR60, T102.3. Interim vitals; HR190, RR60, T101.6. End of infusion vitals; HR198, RR60, T101.8. No adverse reaction. | JoAnne Flynn | https://fairdomhub.org/samples/59185 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 5 | milligram | Saline | Control | Treatment | NHP-220830FLY-39 | Flynn Lab | 2021-06-02 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-25 | 10121-210604 | JoAnne Flynn | https://fairdomhub.org/samples/59186 | M. tuberculosis | Infection | Intrabronchially | 15 | CFU | Blood; Infection; Treatment | Complete Blood Count Blood Test; Peripheral Blood Mononuclear Cells Freeze | NHP-220830FLY-39 | Flynn Lab | 2021-06-04 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-26 | 10121-210616 | Infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR169, RR40, T100.8. Interim vitals; HR170, RR40, T 100.8. End of infusion vitals; HR179, RR44, T 100.7. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59187 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 4 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-39 | Flynn Lab | 2021-06-16 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-27 | 10121-210622 | JoAnne Flynn | https://fairdomhub.org/samples/59188 | Blood | Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-39 | Flynn Lab | 2021-06-22 00:00:00 | |||||||||||||||||||||||||||||
| PAV-220830FLY-28 | 10121-210629 | infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion., predosing vitals; HR200, RR44, T101.5, interim vitals; HR216, RR46, T101. end of infusion vitals; HR216, RR46, T 101.2. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59189 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 4 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-39 | Flynn Lab | 2021-06-29 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-29 | 10121-210702 | JoAnne Flynn | https://fairdomhub.org/samples/59190 | Scan | P1067 | PET/CT | NHP-220830FLY-39 | Flynn Lab | 2021-07-02 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-30 | 10121-210714 | infusion premed administered 30 minutes prior to infusion., infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR200, RR60, T101.6. Interim vitals; HR204, RR66, T101.3. End of infusion vitals; HR200, RR60, T100.9. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59191 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 5 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-39 | Flynn Lab | 2021-07-14 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-31 | 10121-210730 | JoAnne Flynn | https://fairdomhub.org/samples/59192 | Scan | P1084 | PET/CT | NHP-220830FLY-39 | Flynn Lab | 2021-07-30 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-32 | 10121-210802 | JoAnne Flynn | https://fairdomhub.org/samples/59193 | Blood; Necropsy | NHP-220830FLY-39 | Flynn Lab | 2021-08-02 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-33 | 10221-201116 | Administered at vendor. | JoAnne Flynn | https://fairdomhub.org/samples/59194 | BCG inoculation | Vaccination | Intravenously | 2 | milliliter | BAC-241002NIH-1 | Treatment; Blood; Tissue Extraction | NHP-220830FLY-40 | VRC (NIH) | 2020-11-16 00:00:00 | |||||||||||||||||||||||
| PAV-220830FLY-34 | 10221-210322 | 1st strongyloides treatment. | JoAnne Flynn | https://fairdomhub.org/samples/59195 | Pyrantel | Medication | Orally | 73.7 | milligram | Treatment | NHP-220830FLY-40 | Flynn Lab | 2021-03-22 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-35 | 10221-210329 | 2nd strongyloides treatment. | JoAnne Flynn | https://fairdomhub.org/samples/59196 | Pyrantel | Medication | Orally | 73.7 | milligram | Treatment | NHP-220830FLY-40 | Flynn Lab | 2021-03-29 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-36 | 10221-210412 | 3rd strongyloides treatment. | JoAnne Flynn | https://fairdomhub.org/samples/59197 | Pyrantel | Medication | Orally | 73.7 | milligram | Treatment | NHP-220830FLY-40 | Flynn Lab | 2021-04-12 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-37 | 10221-210505 | Infusion premed administered 30 minutes prior to infusion at 8;45 am., LN Bx, Infusion premed administered 30 minutes prior to infusion at 8;45 am., Pre-dosing vitals; HR 150, RR48, T 100.7. Interim vitals; HR 152, RR 52, T 99.9. End of infusion vitals; HR 156, RR 58, T 100.1. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59198 | Acetaminophen | Medication | Orally | 80 | milligram | Banamine | Medication | Intramuscularly | 13.4 | milligram | Diphenhydramine | Medication | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-40 | Flynn Lab | 2021-05-05 00:00:00 | Intramuscularly | 6 | milligram | Saline | Control | Intravenously | 50 | milliliter | ||||||||
| PAV-220830FLY-38 | 10221-210520 | Infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion., Pre-dosing vitals; HR151, RR40, T101.7. Interim vitals; HR159, RR40, T101.5. End of infusion vitals; HR163, RR48, T 101.2. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59199 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Blood; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-40 | Flynn Lab | 2021-05-20 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-39 | 10221-210527 | LN Bx | JoAnne Flynn | https://fairdomhub.org/samples/59200 | Banamine | Medication | Intramuscularly | 12.2 | milligram | Tissue Extraction; Treatment | NHP-220830FLY-40 | Flynn Lab | 2021-05-27 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-40 | 10221-210602 | Infusion premed; administered 30 minutes prior to infusion. , infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR144,RR48,T102.2. Interim vitals; HR131, RR60, T 102.4. End of infusion vitals; HR140, RR60, T 101.7. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59201 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Treatment | NHP-220830FLY-40 | Flynn Lab | 2021-06-02 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-41 | 10221-210604 | JoAnne Flynn | https://fairdomhub.org/samples/59202 | M. tuberculosis | Infection | Intrabronchially | 15 | CFU | Blood; Infection; Treatment | Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-40 | Flynn Lab | 2021-06-04 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-42 | 10221-210616 | Infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR156, RR36, T99.9. Interim vitals; HR157, RR36, T 99.7. End of infusion vitals; HR159, RR36, T99.6. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59203 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-40 | Flynn Lab | 2021-06-16 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-43 | 10221-210622 | JoAnne Flynn | https://fairdomhub.org/samples/59204 | Blood | Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-40 | Flynn Lab | 2021-06-22 00:00:00 | |||||||||||||||||||||||||||||
| PAV-220830FLY-44 | 10221-210629 | infusion premed administered 30 minutes prior to infusion., infusion premed administered 30 minutes prior to infusion. , predosing vitals; HR140, RR50, T102.7, interim vitals; HR139, RR52, T102.2. end of infusion vitals; HR138, RR52, T102. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59205 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-40 | Flynn Lab | 2021-06-29 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-45 | 10221-210702 | JoAnne Flynn | https://fairdomhub.org/samples/59206 | Scan | P1068 | PET/CT | NHP-220830FLY-40 | Flynn Lab | 2021-07-02 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-46 | 10221-210714 | infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR137, RR52, T102.2. Interim vitals; HR146, RR52, T101.3. End of infusion vitals; HR147, RR55, T100.6. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59207 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-40 | Flynn Lab | 2021-07-14 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-47 | 10221-210723 | JoAnne Flynn | https://fairdomhub.org/samples/59208 | Scan | P1079 | PET/CT | NHP-220830FLY-40 | Flynn Lab | 2021-07-23 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-48 | 10221-210727 | JoAnne Flynn | https://fairdomhub.org/samples/59209 | Blood; Necropsy | NHP-220830FLY-40 | Flynn Lab | 2021-07-27 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-90 | 19521-210330 | Administered at vendor. | JoAnne Flynn | https://fairdomhub.org/samples/59251 | BCG inoculation | Vaccination | Intravenously | 2 | milliliter | BAC-241002NIH-1 | Treatment; Blood; Tissue Extraction | NHP-220830FLY-44 | VRC (NIH) | 2021-03-30 00:00:00 | |||||||||||||||||||||||
| PAV-220830FLY-91 | 19521-210816 | infusion premed administered 30 minutes prior to infusion., LN Bx, infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR182, RR56, T100. Interim vitals; HR173, RR48, T99.8. End of infusion vitals; HR162, RR48, T99.6. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59252 | Acetaminophen | Medication | Orally | 80 | milligram | Banamine | Medication | Intramuscularly | 15.8 | milligram | Diphenhydramine | Medication | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-44 | Flynn Lab | 2021-08-16 00:00:00 | Intramuscularly | 7.5 | milligram | Saline | Control | Intravenously | 50 | milliliter | ||||||||
| PAV-220830FLY-92 | 19521-210817 | Possible pain associated with redness/irritation around lymph node biopsy site. | JoAnne Flynn | https://fairdomhub.org/samples/59253 | Acetaminophen | Medication | Orally | 80 | milligram | Treatment | NHP-220830FLY-44 | Flynn Lab | 2021-08-17 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-93 | 19521-210830 | infusion premed administered 30 minutes prior to infusion. , infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR138, RR48, T 101.4 Interim vitals; HR 139, RR 48, T 101.2. End of infusion vitals; HR 145, RR 56, T101.5. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59254 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-44 | Flynn Lab | 2021-08-30 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-94 | 19521-210907 | LN Bx | JoAnne Flynn | https://fairdomhub.org/samples/59255 | Banamine | Medication | Intramuscularly | 15.2 | milligram | Blood; Tissue Extraction; Treatment | Peripheral Blood Mononuclear Cells ELI Spot | NHP-220830FLY-44 | Flynn Lab | 2021-09-07 00:00:00 | |||||||||||||||||||||||
| PAV-220830FLY-95 | 19521-210913 | infusion premed administered 30 minutes prior to infusion. , infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR132, RR40, T100.4. Interim vitals; HR135, RR40, T100.4. End of infusion vitals; HR139, RR40, T100.2. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59256 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Treatment | NHP-220830FLY-44 | Flynn Lab | 2021-09-13 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-96 | 19521-210916 | JoAnne Flynn | https://fairdomhub.org/samples/59257 | M. tuberculosis | Infection | Intrabronchially | 15 | CFU | Blood; Infection; Treatment | Peripheral Blood Mononuclear Cells Freeze; Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-44 | Flynn Lab | 2021-09-16 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-97 | 19521-210929 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitalsHR 141, RR 56, T 101.2. Interim vitalsHR 138, RR 48, T 101.1. End of infusion vitals; HR 139, RR 56, T 100.8. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59258 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-44 | Flynn Lab | 2021-09-29 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-98 | 19521-211005 | JoAnne Flynn | https://fairdomhub.org/samples/59259 | Blood | Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-44 | Flynn Lab | 2021-10-05 00:00:00 | |||||||||||||||||||||||||||||
| PAV-220830FLY-99 | 19521-211011 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitalsHR 142, RR 48, T 102.1. Interim vitals; HR 142, RR 48, T 101.2. End of infusion vitals; HR 139, RR 48, T 100.7. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59260 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-44 | Flynn Lab | 2021-10-11 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-100 | 19521-211014 | JoAnne Flynn | https://fairdomhub.org/samples/59261 | Scan | P1117 | PET/CT | NHP-220830FLY-44 | Flynn Lab | 2021-10-14 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-101 | 19521-211026 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , Pre-dosing vitals; HR 134, RR 44, T102.0. Interim vitals; HR 140, RR 40, T 101.1. End of infusion vitals; HR 160, RR 56, T 101.2. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59262 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-44 | Flynn Lab | 2021-10-26 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-102 | 19521-211109 | JoAnne Flynn | https://fairdomhub.org/samples/59263 | Scan | P1146 | PET/CT | NHP-220830FLY-44 | Flynn Lab | 2021-11-09 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-103 | 19521-211111 | JoAnne Flynn | https://fairdomhub.org/samples/59264 | Blood; Necropsy | NHP-220830FLY-44 | Flynn Lab | 2021-11-11 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-174 | 20121-210330 | Administered at Vendor. | JoAnne Flynn | https://fairdomhub.org/samples/59303 | BCG inoculation | Vaccination | Intravenously | 2 | milliliter | BAC-241002NIH-1 | Treatment; Blood; Tissue Extraction | NHP-220830FLY-50 | VRC (NIH) | 2021-03-30 00:00:00 | |||||||||||||||||||||||
| PAV-220830FLY-175 | 20121-210812 | Loose stool | JoAnne Flynn | https://fairdomhub.org/samples/59304 | Fiber Gummies | Medication | Orally | Treatment | NHP-220830FLY-50 | Flynn Lab | 2021-08-12 00:00:00 | ||||||||||||||||||||||||||
| PAV-220830FLY-176 | 20121-210823 | infusion premed administered 30 minutes prior to infusion. , LN Bx, infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR139, RR40, T100.7. Interim vitals; HR142, RR40, T100.7. End of infusion vitals; HR147, RR44, T100.9. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59305 | Acetaminophen | Medication | Orally | 80 | milligram | Banamine | Medication | Intramuscularly | 12.6 | milligram | Diphenhydramine | Medication | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-50 | Flynn Lab | 2021-08-23 00:00:00 | Intramuscularly | 7 | milligram | Saline | Control | Intravenously | 50 | milliliter | ||||||||
| PAV-220830FLY-177 | 20121-210908 | infusion premed administered 30 minutes prior to infusion. , infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR134, RR60, T101. Interim vitals; HR 135, RR56, T 100.8. End of infusion vitals; HR 138, RR60, T 100.8. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59306 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Blood; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-50 | Flynn Lab | 2021-09-08 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-178 | 20121-210913 | LN Bx | JoAnne Flynn | https://fairdomhub.org/samples/59307 | Banamine | Medication | Intramuscularly | 13.2 | milligram | Tissue Extraction; Treatment | NHP-220830FLY-50 | Flynn Lab | 2021-09-13 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-179 | 20121-210920 | Infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 124, RR40, T 99.9. Interim vitals; HR 123, RR38, T 99.8. End of infusion vitals; HR 128, RR 42, T 99.7. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59308 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Treatment | NHP-220830FLY-50 | Flynn Lab | 2021-09-20 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-180 | 20121-210923 | JoAnne Flynn | https://fairdomhub.org/samples/59309 | M. tuberculosis | Infection | Intrabronchially | 5 | CFU | Blood; Infection; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-50 | Flynn Lab | 2021-09-23 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-181 | 20121-211006 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitalsHR 166, RR 56, T100.9 Interim vitals; HR 137, RR 56, T100.6. End of infusion vitals; HR 150, RR 60, T 100.4. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59310 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-50 | Flynn Lab | 2021-10-06 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-182 | 20121-211012 | JoAnne Flynn | https://fairdomhub.org/samples/59311 | Blood | Complete Blood Count Blood Test; Fluorescence Activated Cell Sorting | NHP-220830FLY-50 | Flynn Lab | 2021-10-12 00:00:00 | |||||||||||||||||||||||||||||
| PAV-220830FLY-183 | 20121-211020 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 118, RR 48, T 100.3. Interim vitals; HR 126, RR 42, T 100.7. End of infusion vitals; HR 140, RR 40, T 99.9. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59312 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-50 | Flynn Lab | 2021-10-20 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-184 | 20121-211021 | JoAnne Flynn | https://fairdomhub.org/samples/59313 | Scan | P1127 | PET/CT | NHP-220830FLY-50 | Flynn Lab | 2021-10-21 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-185 | 20121-211102 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR 132, RR 42, T 101.8. Interim vitals; HR 134, RR 42, T 100.5. End of infusion vitals; HR 145, RR 46, T 99.9. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59314 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-50 | Flynn Lab | 2021-11-02 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-186 | 20121-211119 | JoAnne Flynn | https://fairdomhub.org/samples/59315 | Scan | P1162 | PET/CT | NHP-220830FLY-50 | Flynn Lab | 2021-11-19 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-187 | 20121-211123 | JoAnne Flynn | https://fairdomhub.org/samples/59316 | Blood; Necropsy | NHP-220830FLY-50 | Flynn Lab | 2021-11-23 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-188 | 20221-210330 | Administered at Vendor. | JoAnne Flynn | https://fairdomhub.org/samples/59317 | BCG inoculation | Vaccination | Intravenously | 2 | milliliter | BAC-241002NIH-1 | Treatment; Blood; Tissue Extraction | NHP-220830FLY-51 | VRC (NIH) | 2021-03-30 00:00:00 | |||||||||||||||||||||||
| PAV-220830FLY-189 | 20221-210823 | infusion premed administered 30 minutes prior to infusion., LN Bx, infusion premed administered 30 minutes prior to infusion. , predosing vitals; HR154, RR36, T 102. Interim vitals; HR154, RR36, T101.8. End of infusion vitals; HR157, RR36, T101.7. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59318 | Acetaminophen | Medication | Orally | 80 | milligram | Banamine | Medication | Intramuscularly | 12.6 | milligram | Diphenhydramine | Medication | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-51 | Flynn Lab | 2021-08-23 00:00:00 | Intramuscularly | 6 | milligram | Saline | Control | Intravenously | 50 | milliliter | ||||||||
| PAV-220830FLY-190 | 20221-210908 | infusion premed administered 30 minutes prior to infusion. , infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR145, RR32, T100.1. Interim vitals; HR150, RR32, T99.7. End of infusion vitals; HR151, RR34, T99.5. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59319 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Blood; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-51 | Flynn Lab | 2021-09-08 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-191 | 20221-210913 | LN Bx | JoAnne Flynn | https://fairdomhub.org/samples/59320 | Banamine | Medication | Intramuscularly | 12.6 | milligram | Tissue Extraction; Treatment | NHP-220830FLY-51 | Flynn Lab | 2021-09-13 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-192 | 20221-210920 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 162, RR56, T 101.6. Interim vitals; HR 153, RR48, T 101.5. End of infusion vitals; HR 151, RR 56, T 101.2. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59321 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Treatment | NHP-220830FLY-51 | Flynn Lab | 2021-09-20 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-193 | 20221-210923 | JoAnne Flynn | https://fairdomhub.org/samples/59322 | M. tuberculosis | Infection | Intrabronchially | 5 | CFU | Blood; Infection; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-51 | Flynn Lab | 2021-09-23 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-194 | 20221-211006 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitalsHR 145, RR 36, T102.6 Interim vitals; HR 149, RR 36, T101.8. End of infusion vitals; HR 156, RR 36, T 101.2. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59323 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-51 | Flynn Lab | 2021-10-06 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-195 | 20221-211012 | JoAnne Flynn | https://fairdomhub.org/samples/59324 | Blood | Complete Blood Count Blood Test; Fluorescence Activated Cell Sorting | NHP-220830FLY-51 | Flynn Lab | 2021-10-12 00:00:00 | |||||||||||||||||||||||||||||
| PAV-220830FLY-196 | 20221-211020 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 139, RR 42, T 101.9. Interim vitals; HR 135, RR 40, T 101.2. End of infusion vitals; HR 134, RR 40, T 100.0. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59325 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-51 | Flynn Lab | 2021-10-20 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-197 | 20221-211021 | JoAnne Flynn | https://fairdomhub.org/samples/59326 | Scan | P1128 | PET/CT | NHP-220830FLY-51 | Flynn Lab | 2021-10-21 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-198 | 20221-211102 | Infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 167, RR 38, T 102.1. Interim vitals; HR 157, RR 40, T 101.9. End of infusion vitals; HR 150, RR 42, T 101.2. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59327 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-51 | Flynn Lab | 2021-11-02 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-199 | 20221-211116 | JoAnne Flynn | https://fairdomhub.org/samples/59328 | Scan | P1159 | PET/CT | NHP-220830FLY-51 | Flynn Lab | 2021-11-16 00:00:00 | ||||||||||||||||||||||||||||
| PAV-220830FLY-200 | 20221-211117 | JoAnne Flynn | https://fairdomhub.org/samples/59329 | Blood; Necropsy | NHP-220830FLY-51 | Flynn Lab | 2021-11-17 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-240 | 20621-210330 | Administered at Vendor. | JoAnne Flynn | BCG inoculation | Vaccination | Intravenously | 2 | milliliter | BAC-241002NIH-1 | Treatment; Blood; Tissue Extraction | NHP-220830FLY-55 | VRC (NIH) | 2021-03-30 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-241 | 20621-210825 | Infusion premed administered 30 minutes prior to infusion. , LN Bx, infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR174, RR60, T 99.7. Interim vitals; HR167, RR58, T99.7. End of infusion vitals; HR 173, RR60, T99.5. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Banamine | Medication | Intramuscularly | 14.8 | milligram | Diphenhydramine | Medication | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-55 | Flynn Lab | 2021-08-25 00:00:00 | Intramuscularly | 7 | milligram | Saline | Control | Intravenously | 50 | milliliter | |||||||||
| PAV-220830FLY-242 | 20621-210910 | infusion premed administered 30 minutes prior to infusion. , infusion oremed administered 30 minutes prior to infusion., pre-dosing vitals; HR132, RR56, T101.0. Interim vitals; HR141, RR48, T100.8. End of infusion vitals; HR146, RR56, T100.6. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-55 | Flynn Lab | 2021-09-10 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-243 | 20621-210915 | LN bx | JoAnne Flynn | Banamine | Medication | Intramuscularly | 15.2 | milligram | Tissue Extraction; Treatment | NHP-220830FLY-55 | Flynn Lab | 2021-09-15 00:00:00 | |||||||||||||||||||||||||
| PAV-220830FLY-244 | 20621-210921 | Infusion premed administered 30 minutes prior to infusion., Infusion premed administered 30 minutes prior to infusion., pre-dosing vitals; HR 170, RR40, T 1024. Interim vitals; HR 165, RR44, T 100.9. End of infusion vitals; HR 159, RR 40, T 102.1. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 7 | milligram | Saline | Control | Treatment | NHP-220830FLY-55 | Flynn Lab | 2021-09-21 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||||
| PAV-220830FLY-245 | 20621-210923 | JoAnne Flynn | M. tuberculosis | Infection | Intrabronchially | 5 | CFU | Blood; Infection; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-55 | Flynn Lab | 2021-09-23 00:00:00 | |||||||||||||||||||||||||
| PAV-220830FLY-246 | 20621-211007 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitalsHR 145, RR 40, T100.9 Interim vitals; HR 148, RR 40, T100.9. End of infusion vitals; HR 153, RR 40, T 100.7. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-55 | Flynn Lab | 2021-10-07 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-247 | 20621-211012 | JoAnne Flynn | Blood | Complete Blood Count Blood Test; Fluorescence Activated Cell Sorting | NHP-220830FLY-55 | Flynn Lab | 2021-10-12 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-248 | 20621-211018 | JoAnne Flynn | Scan | PET/CT | NHP-220830FLY-55 | Flynn Lab | 2021-10-18 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-249 | 20621-211021 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , Pre-dosing vitals; HR 143, RR 56, T102.1. Interim vitals; HR 155, RR 65, T 101.2. End of infusion vitals; HR 137, RR 56, T 101.0. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-55 | Flynn Lab | 2021-10-21 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-250 | 20621-211103 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 132, RR 36, T 101.7. Interim vitals; HR 136, RR 40, T 101.7. End of infusion vitals; HR 150, RR 40, T 101.5. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-55 | Flynn Lab | 2021-11-03 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-251 | 20621-211116 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 153, RR 48, T 101.4. Interim vitals; HR 160, RR 56, T 101.0. End of infusion vitals; HR 170, RR 56, T 100.7. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze; Complete Blood Count Blood Test | NHP-220830FLY-55 | Flynn Lab | 2021-11-16 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-252 | 20621-211118 | JoAnne Flynn | Scan | PET/CT | NHP-220830FLY-55 | Flynn Lab | 2021-11-18 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-253 | 20621-211129 | Infusion premed administered 30 minutes prior to infusion. , Infusion premed administered 30 minutes prior to infusion. , pre-dosing vitals; HR 126, RR 48, T 100.9. Interim vitals; HR 145, RR 48, T 100.9. End of infusion vitals; HR 142, RR 48, T 100.7. No adverse reactions. | JoAnne Flynn | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 8 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Erythrocyte Sedimentation Rate; Peripheral Blood Mononuclear Cells Freeze | NHP-220830FLY-55 | Flynn Lab | 2021-11-29 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-254 | 20621-211210 | JoAnne Flynn | Scan | PET/CT | NHP-220830FLY-55 | Flynn Lab | 2021-12-10 00:00:00 | ||||||||||||||||||||||||||||||
| PAV-220830FLY-255 | 20621-211213 | JoAnne Flynn | Blood; Necropsy | NHP-220830FLY-55 | Flynn Lab | 2021-12-13 00:00:00 | |||||||||||||||||||||||||||||||
| PAV-220830FLY-295 | 21219-190416 | JoAnne Flynn | https://fairdomhub.org/samples/59408 | BCG inoculation | Vaccination | Intravenously | 2 | milliliter | BAC-241002NIH-1 | Treatment; Blood; Tissue Extraction | NHP-220830FLY-59 | VRC (NIH) | 2019-04-16 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-296 | 21219-190814 | JoAnne Flynn | https://fairdomhub.org/samples/59409 | Blood | Peripheral Blood Mononuclear Cells Freeze; Erythrocyte Sedimentation Rate | NHP-220830FLY-59 | Flynn Lab | 2019-08-14 00:00:00 | |||||||||||||||||||||||||||||
| PAV-220830FLY-297 | 21219-190830 | infusion premed, LN Bx, infusion premed, pre-dosing vitals; HR 180, RR 42, T 100.3. Interim vitals; HR 170, RR 36 T 99.8. End of infusion vitals; HR 170, RR 30, T 98.6. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59410 | Acetaminophen | Medication | Orally | 80 | milligram | Banamine | Medication | Intramuscularly | 9.6 | milligram | Diphenhydramine | Medication | Blood; Tissue Extraction; Treatment | Peripheral Blood Mononuclear Cells Freeze; Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-59 | Flynn Lab | 2019-08-30 00:00:00 | Intramuscularly | 6 | milligram | Saline | Control | Intravenously | 50 | milliliter | ||||||||
| PAV-220830FLY-298 | 21219-190912 | infusion premed, infusion premed., pre-dosing vitals; HR 180, RR 50, T102.3. Interim vitals; HR 170, RR 50, T 102.3. End of infusion vitals; HR 170, RR 50, T 102.1. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59411 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Blood; Treatment | Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test | NHP-220830FLY-59 | Flynn Lab | 2019-09-12 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-299 | 21219-190920 | LN bx | JoAnne Flynn | https://fairdomhub.org/samples/59412 | Banamine | Medication | Intramuscularly | 9.6 | milligram | Tissue Extraction; Treatment | NHP-220830FLY-59 | Flynn Lab | 2019-09-20 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-300 | 21219-190925 | Infusion premed. , Infusion premed. , pre-dosing vitals; HR 180, RR 50, T 102.9. Interim vitals; HR 170, RR 50, T 102.3. End of infusion vitals; HR 170, RR 58, T 102.1. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59413 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Treatment | NHP-220830FLY-59 | Flynn Lab | 2019-09-25 00:00:00 | Intravenously | 50 | milliliter | ||||||||||||||
| PAV-220830FLY-301 | 21219-190926 | JoAnne Flynn | https://fairdomhub.org/samples/59414 | M. tuberculosis | Infection | Intrabronchially | 39 | CFU | Blood; Infection; Treatment | Peripheral Blood Mononuclear Cells Freeze; Erythrocyte Sedimentation Rate; Complete Blood Count Blood Test; Fluorescence Activated Cell Sorting | NHP-220830FLY-59 | Flynn Lab | 2019-09-26 00:00:00 | ||||||||||||||||||||||||
| PAV-220830FLY-302 | 21219-191011 | saline control infusion, saline control infusion, pre-dosing vitals; HR 190, RR 40, T 101.5. Interim vitals; HR 190, RR 40, T 101.5. End of infusion vitals; HR 180, RR 40, T 101.4. No adverse reactions. | JoAnne Flynn | https://fairdomhub.org/samples/59415 | Acetaminophen | Medication | Orally | 80 | milligram | Diphenhydramine | Medication | Intramuscularly | 6 | milligram | Saline | Control | Blood; Tissue Extraction; Treatment | Peripheral Blood Mononuclear Cells Freeze; Erythrocyte Sedimentation Rate; Complete Blood Count Blood Test; Fluorescence Activated Cell Sorting | NHP-220830FLY-59 | Flynn Lab | 2019-10-11 00:00:00 | Intravenously | 50 | milliliter | |||||||||||||
| PAV-220830FLY-303 | 21219-191015 | JoAnne Flynn | https://fairdomhub.org/samples/59416 | Blood | Fluorescence Activated Cell Sorting | NHP-220830FLY-59 | Flynn Lab | 2019-10-15 00:00:00 | |||||||||||||||||||||||||||||
| PAV-220830FLY-304 | 21219-191021 | JoAnne Flynn | https://fairdomhub.org/samples/59417 | Scan | P0437 | PET/CT | NHP-220830FLY-59 | Flynn Lab | 2019-10-21 00:00:00 |
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
| UID | Name | Scientist | SampleCreationDate | Parent | Type | Protocol | Notes | Treatment | TreatmentType | TreatmentDose | TreatmentDoseUnits | Treatment2 | Treatment2Type | Treatment2Dose | Treatment2DoseUnits | ||
| TIS-240821SED-183 | 10221-210304-PBMC_Stim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-62 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-91 | 10221-210304-PBMC_Unstim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-62 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-184 | 10221-210414-PBMC_Stim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-63 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-92 | 10221-210414-PBMC_Unstim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-63 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-185 | 10221-210429-PBMC_Stim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-64 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-93 | 10221-210429-PBMC_Unstim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-64 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-187 | 10221-210526-BAL_Stim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-65 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-95 | 10221-210526-BAL_Unstim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-65 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-186 | 10221-210526-PBMC_Stim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-65 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-94 | 10221-210526-PBMC_Unstim | Robert Seder | 2023-12-20 00:00:00 | PAV-240821SED-65 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-220914SED-75 | 17819_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-31 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-33 | 17819_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-31 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-76 | 17919_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-32 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-34 | 17919_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-32 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-83 | 18019_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-39 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-41 | 18019_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-39 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-79 | 18119_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-35 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-37 | 18119_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-35 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-82 | 18219_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-38 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-40 | 18219_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-38 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-84 | 18319_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-40 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-42 | 18319_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-40 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-80 | 18419_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-36 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-38 | 18419_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-36 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-81 | 18519_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-37 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-39 | 18519_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-37 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-77 | 18619_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-33 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-35 | 18619_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-33 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-220914SED-78 | 18719_Wk14_BAL_Stim | Joshua Peters | PAV-220914FLY-34 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | Tuberculin Purified Protein Derivative | Stimulation | 20 | microgram per milliliter | Overnight | ||||
| TIS-220914SED-36 | 18719_Wk14_BAL_Unstim | Joshua Peters | PAV-220914FLY-34 | Bronchoalveolar lavage | https://fairdomhub.org/sops/810 | Lung | 60 | milliliter | |||||||||
| TIS-240821SED-124 | 19521-210302-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-16 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-32 | 19521-210302-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-16 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-125 | 19521-210427-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-17 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-33 | 19521-210427-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-17 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-127 | 19521-210524-BAL_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-18 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-35 | 19521-210524-BAL_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-18 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-126 | 19521-210524-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-18 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-34 | 19521-210524-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-18 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-119 | 20221-210302-PBMC_Stim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-12 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-27 | 20221-210302-PBMC_Unstim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-12 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-120 | 20221-210412-PBMC_Stim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-13 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-28 | 20221-210412-PBMC_Unstim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-13 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-121 | 20221-210427-PBMC_Stim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-14 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-29 | 20221-210427-PBMC_Unstim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-14 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-123 | 20221-210524-BAL_Stim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-15 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-31 | 20221-210524-BAL_Unstim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-15 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-122 | 20221-210524-PBMC_Stim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-15 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-30 | 20221-210524-PBMC_Unstim | Robert Seder | 2023-12-13 00:00:00 | PAV-240821SED-15 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-173 | 21219-190325-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-54 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-81 | 21219-190325-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-54 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-174 | 21219-190430-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-55 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-82 | 21219-190430-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-55 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-175 | 21219-190513-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-56 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-83 | 21219-190513-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-56 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-177 | 21219-190610-BAL_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-57 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-85 | 21219-190610-BAL_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-57 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-176 | 21219-190610-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-57 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-84 | 21219-190610-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-57 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-178 | 21519-190328-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-58 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-86 | 21519-190328-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-58 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-179 | 21519-190502-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-59 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-87 | 21519-190502-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-59 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-180 | 21519-190515-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-60 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-88 | 21519-190515-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-60 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-182 | 21519-190611-BAL_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-61 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-90 | 21519-190611-BAL_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-61 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-181 | 21519-190611-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-61 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-89 | 21519-190611-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-61 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-168 | 21819-190325-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-50 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-76 | 21819-190325-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-50 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-169 | 21819-190430-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-51 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-77 | 21819-190430-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-51 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-170 | 21819-190513-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-52 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-78 | 21819-190513-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-52 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-172 | 21819-190610-BAL_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-53 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-80 | 21819-190610-BAL_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-53 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-171 | 21819-190610-PBMC_Stim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-53 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-79 | 21819-190610-PBMC_Unstim | Robert Seder | 2024-01-03 00:00:00 | PAV-240821SED-53 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-158 | 21919-190328-PBMC_Stim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-42 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-66 | 21919-190328-PBMC_Unstim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-42 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-159 | 21919-190502-PBMC_Stim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-43 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-67 | 21919-190502-PBMC_Unstim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-43 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-160 | 21919-190515-PBMC_Stim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-44 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-68 | 21919-190515-PBMC_Unstim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-44 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-162 | 21919-190611-BAL_Stim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-45 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-70 | 21919-190611-BAL_Unstim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-45 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-161 | 21919-190611-PBMC_Stim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-45 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-69 | 21919-190611-PBMC_Unstim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-45 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-139 | 22119-190325-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-27 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-47 | 22119-190325-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-27 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-140 | 22119-190430-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-28 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-48 | 22119-190430-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-28 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-141 | 22119-190513-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-29 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-49 | 22119-190513-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-29 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-143 | 22119-190610-BAL_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-30 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-51 | 22119-190610-BAL_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-30 | Bronchoalveolar Lavage | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-142 | 22119-190610-PBMC_Stim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-30 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL | ||
| TIS-240821SED-50 | 22119-190610-PBMC_Unstim | Robert Seder | 2024-01-10 00:00:00 | PAV-240821SED-30 | Blood | https://fairdomhub.org/sops/810 | Unstimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | ||||||
| TIS-240821SED-163 | 22619-190328-PBMC_Stim | Robert Seder | 2024-01-17 00:00:00 | PAV-240821SED-46 | Blood | https://fairdomhub.org/sops/810 | Stimulated | Brefalden A/GolgiStop Protein Transport Inhibitor | Transport Inhibitor | 10 | ug/mL | Mtb lysate | Stimulation | 100 | ug/mL |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
| UID | Name | Analyte | Catalog# | Vendor | Clone | Lot# | Fluorophore | ExperimentType | Scientist |
| AB-240822SED-1 | CD8a | CD8a | 566452 | BD Horizon | RPA-T8 | 3027062 | BB700 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-2 | CD103 | CD103 | IM1856U | Beckman Coulter | 2G5 | 200089 | FITC | Flow Cytometry | Steven Makatsa |
| AB-240822SED-3 | CD25 | CD25 | 568688 | BD Biosciences | 2A3 | 2259586 | RB780 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-4 | CD57 | CD57 | 130-111-815 | Miltenyi | REA769 | 372216 | PE-Vio 615 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-5 | CD158 | CD158 | 339506 | BioLegend | HP-MA4 | B353555 | PE | Flow Cytometry | Steven Makatsa |
| AB-240822SED-6 | CD16 | CD16 | 560195 | BD Biosciences | 3G8 | 2175053 | APC-H7 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-7 | NKG2A | NKG2A | A60797 | Beckman Coulter | Z199 | 200060 | APC | Flow Cytometry | Steven Makatsa |
| AB-240822SED-8 | CD69 | CD69 | 310932 | BioLegend | FN50 | B370748 | BV785 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-9 | CD107a | CD107a | 328638 | BioLegend | H4A3 | B381009 | BV650 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-10 | LD Zombie Yellow | LD Zombie Yellow | 77168 | BioLegend | N/A | B337269 | BV570 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-11 | Granzyme B | Granzyme B | 563388 | BD Horizon | GB11 | 2355331 | BV510 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-12 | IFNg | IFNg | 560371 | BD Horizon | B27 | 1271087 | V450 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-13 | NKG2D | NKG2D | 748426 | BD Biosciences | 1D11 | 3146212 | BUV737 | Flow Cytometry | Steven Makatsa |
| AB-240822SED-14 | CD3 | CD3 | 564117 | BD Horizon | SP34-2 | 3040272 | BUV395 | Flow Cytometry | Steven Makatsa |
| AB-230221SES-1 | CD68 106 | CD68 | 916104 | BioLegend | KP1 | B283618 | Cadmium | CytoF | Steven Makatsa |
| AB-230221SES-2 | CD8a 111 | CD8a | 301053 | BioLegend | RPA-T8 | 301053 | Cadmium | CytoF | Steven Makatsa |
| AB-230221SES-3 | TCR Vγ9 112 | TCR Vγ9 | 331301 | BioLegend | B3 | B330499 | Cadmium | CytoF | Steven Makatsa |
| AB-230221SES-4 | CD8b 113 | CD8b | NB100-65928 | eBiosciences | SIDI8BEE | 2472578 | Cadmium | CytoF | Steven Makatsa |
| AB-230221SES-5 | CD4 114 | CD4 | 550625 | BD Pharmingen | L200 | 6280954 | Cadmium | CytoF | Steven Makatsa |
| AB-230221SES-6 | CD45 116 | CD45 | 552566 | BD Pharmingen | D058-1283 | 9301693 | Cadmium | CytoF | Steven Makatsa |
| AB-230221SES-7 | CCL4 142 | CCL4 | MA5-23713 | Invitrogen | 24006 | WA3164791 | Neodymium | CytoF | Steven Makatsa |
| AB-230221SES-8 | CD107a 143 | CD107a | 328601 | BioLegend | H4A3 | B316460 | Neodymium | CytoF | Steven Makatsa |
| AB-230221SES-9 | CD11b (Mac-1) 144 | CD11b (Mac-1) | 3144001B | Fluidigm | ICRF44 | 2012340-01 | Neodymium | CytoF | Steven Makatsa |
| AB-230221SES-10 | CD69 145 | CD69 | 310902 | BioLegend | FN50 | B288994 | Neodymium | CytoF | Steven Makatsa |
| AB-230221SES-11 | CD11c 146 | CD11c | 3146014B | Fluidigm | 3.9 | 2108735-17 | Neodymium | CytoF | Steven Makatsa |
| AB-230221SES-12 | CD20 147 | CD20 | 3147001B | Fluidigm | 2H7 | 2108087-31 | Samarium | CytoF | Steven Makatsa |
| AB-230221SES-13 | IL-17A 148 | IL-17A | 3148008B | Fluidigm | BL168 | 3041304 | Neodymium | CytoF | Steven Makatsa |
| AB-230221SES-14 | CD127 (IL-7Ra) 149 | CD127 (IL-7Ra) | 3149011B | Fluidigm | A019D5 | 2201714-14 | Samarium | CytoF | Steven Makatsa |
| AB-230221SES-15 | CXCL10 150 | CXCL10 | 519501 | BioLegend | J034D6 | B209398 | Neodymium | CytoF | Steven Makatsa |
| AB-230221SES-16 | CD14 151 | CD14 | 3151009B | Fluidigm | M5E2 | 2105043-18 | Europium | CytoF | Steven Makatsa |
| AB-230221SES-17 | TNFa 152 | TNFa | 3152002B | Fluidigm | Mab11 | 1322042 | Samarium | CytoF | Steven Makatsa |
| AB-230221SES-18 | IgD 153 | IgD | 2030-01 | Southern Bio | Polyclonal | J1119-ZH40 | Europium | CytoF | Steven Makatsa |
| AB-230221SES-19 | CD163 154 | CD163 | 3154007B | Fluidigm | GHI/61 | 3321818 | Samarium | CytoF | Steven Makatsa |
| AB-230221SES-20 | IL-1b 155 | IL-1b | 508202 | BioLegend | JK1B-1 | B304045 | Gadolinium | CytoF | Steven Makatsa |
| AB-230221SES-21 | CXCR3 156 | CXCR3 | 3156004B | Fluidigm | G025H7 | 2106162-01 | Gadolinium | CytoF | Steven Makatsa |
| AB-230221SES-22 | IL-2 158 | IL-2 | 3158007B | Fluidigm | MQ1-17H12 | 2111004-23 | Gadolinium | CytoF | Steven Makatsa |
| AB-230221SES-23 | CCR7 159 | CCR7 | 3159003A | Fluidigm | G043H7 | 2103451-24 | Terbium | CytoF | Steven Makatsa |
| AB-230221SES-24 | CD161 160 | CD161 | 339902 | BioLegend | HP-3G10 | B321384 | Gadolinium | CytoF | Steven Makatsa |
| AB-230221SES-25 | CD123 161 | CD123 | 306002 | Biolegend | 6H6 | B254974 | Dysprosium | CytoF | Steven Makatsa |
| AB-230221SES-26 | CD154 162 | CD154 | 310802 | BioLegend | 24-31 | B317101 | Dysprosium | CytoF | Steven Makatsa |
| AB-230221SES-27 | APC Mamu MR1-5-OP-RU 163 | APC Mamu MR1-5-OP-RU | 53972 | NHP Reagent resource | 53972 | Dysprosium | CytoF | Steven Makatsa | |
| AB-230221SES-28 | anti-APC 163 | anti-APC | 3163001B | Fluidigm | N/A | 2009721-23 | Dysprosium | CytoF | Steven Makatsa |
| AB-230221SES-29 | Perforin 164 | Perforin | 3465-3-250 | Mabtech | Pf-80/164 | 7.3 | Dysprosium | CytoF | Steven Makatsa |
| AB-230221SES-30 | Granzyme K 165 | Granzyme K | 370502 | BioLegend | GM26E7 | B322082 | Holmium | CytoF | Steven Makatsa |
| AB-230221SES-31 | IL-10 166 | IL-10 | 3166008B | Fluidigm | JES3-9D7 | 2011082-03 | Erbium | CytoF | Steven Makatsa |
| AB-230221SES-32 | IL-6 167 | IL-6 | 559068 | BD Biosciences | MQ2-6A3 | 134181 | Erbium | CytoF | Steven Makatsa |
| AB-230221SES-33 | IFNg 168 | IFNg | 3168005B | Fluidigm | B27 | 0832005 | Erbium | CytoF | Steven Makatsa |
| AB-230221SES-34 | NKG2a 169 | NKG2a | 3169013B | Fluidigm | Z199 | 2801902 | Thulium | CytoF | Steven Makatsa |
| AB-230221SES-35 | CD3 170 | CD3 | 3170007B | Fluidigm | SP34-2 | 1571803 | Erbium | CytoF | Steven Makatsa |
| AB-230221SES-36 | TCRgd 171 | TCRgd | 331202 | BioLegend | B1 | B351135 | Ytterbium | CytoF | Steven Makatsa |
| AB-230221SES-37 | CD206 172 | CD206 | 555953 | BD Biosciences | 19.2 | 1209582 | Ytterbium | CytoF | Steven Makatsa |
| AB-230221SES-38 | Granzyme B 173 | Granzyme B | 3173006B | Fluidigm | GB11 | 2111966-19 | Ytterbium | CytoF | Steven Makatsa |
| AB-230221SES-39 | CD45RA 174 | CD45RA | 556625 | BD Biosciences | 5H9 | 1174483 | Ytterbium | CytoF | Steven Makatsa |
| AB-230221SES-40 | CD28 175 | CD28 | 302902 | BioLegend | CD28.2 | B313851 | Lutetium | CytoF | Steven Makatsa |
| AB-230221SES-41 | HLA-DR 176 | HLA-DR | 327002 | BioLegend | LN3 | B281072 | Ytterbium | CytoF | Steven Makatsa |
| AB-230221SES-42 | CD16 209 | CD16 | 3209002B | Fluidigm | 3G8 | 2108033-25 | Bismuth | CytoF | Steven Makatsa |
| AB-230221SES-43 | Cell-ID Cisplatin 195 | Cell-ID Cisplatin | 201064 | Fluidigm | Platinum | CytoF | Steven Makatsa | ||
| AB-230221SES-44 | Cell-ID Intercalator 191 | Cell-ID Intercalator | 201192A | Fluidigm | Iridium | CytoF | Steven Makatsa | ||
| AB-230406SES-1 | CyTOF Calibration Beads | EQ Four Element Calibration Beads | 201078 | Fluidigm | Cerium, Europium, Holmium, Letetium | CytoF | Steven Makatsa |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | Name | Parent | Scientist | ||||||
| ABP-240826SED-1 | 240706_AB_flow | AB-240822SED-1; AB-240822SED-2; AB-240822SED-3; AB-240822SED-4; AB-240822SED-5; AB-240822SED-6; AB-240822SED-7; AB-240822SED-8; AB-240822SED-9; AB-240822SED-10; AB-240822SED-11; AB-240822SED-12; AB-240822SED-13; AB-240822SED-14 | Steven Makatsa | ||||||
| ABP-241212SED-1 | AB_Cytof | AB-230221SES-1; AB-230221SES-2; AB-230221SES-3; AB-230221SES-4; AB-230221SES-5; AB-230221SES-6; AB-230221SES-7; AB-230221SES-8; AB-230221SES-9; AB-230221SES-10; AB-230221SES-11; AB-230221SES-12; AB-230221SES-13; AB-230221SES-14; AB-230221SES-15; AB-230221SES-16; AB-230221SES-17; AB-230221SES-18; AB-230221SES-19; AB-230221SES-20; AB-230221SES-21; AB-230221SES-22; AB-230221SES-23; AB-230221SES-24; AB-230221SES-25; AB-230221SES-26; AB-230221SES-27; AB-230221SES-28; AB-230221SES-29; AB-230221SES-30; AB-230221SES-31; AB-230221SES-32; AB-230221SES-33; AB-230221SES-34; AB-230221SES-35; AB-230221SES-36; AB-230221SES-37; AB-230221SES-38; AB-230221SES-39; AB-230221SES-40; AB-230221SES-41; AB-230221SES-42; AB-230221SES-43; AB-230221SES-44; AB-230406SES-1 | Steven Makatsa | ||||||
A
B
C
D
E
F
G
H
I
J
K
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
| UID | File_PrimaryData | Link_PrimaryData | Checksum_PrimaryData | SampleCreationDate | Scientist | Parent | Type | Protocol | Repository | RepositoryID |
| D.FCS-250121SED-1 | 20231214_Compensation Controls_CD103 B515 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 6f64db2adf07e4878908af8a1c1785f0 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-2 | 20231214_Compensation Controls_CD107a V655 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | cd332074f19e932c89525958f23a0016 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-3 | 20231214_Compensation Controls_CD158 G575 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 1ec00481500982b9c428d40131f3122d | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-4 | 20231214_Compensation Controls_CD16 R780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 616790c865f87d6d1e708f4258725bd4 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-5 | 20231214_Compensation Controls_CD25 G780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | f8e42d0dd260f0b94c8476981a8c12ff | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-6 | 20231214_Compensation Controls_CD3 U395 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | d7088e4de9ded71c45c12401df1f8282 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-7 | 20231214_Compensation Controls_CD57 G610 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 8ed881ec56c4aeac753e25f5032fee05 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-8 | 20231214_Compensation Controls_CD69 V780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 1ac82a5c968bb8d94173168480c30df0 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-9 | 20231214_Compensation Controls_CD8a B710 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 71bc1804aae11d73192777d751b5918f | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-10 | 20231214_Compensation Controls_IFNg V450 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 5782b94ace21d5dac50233cb44be38c4 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-11 | 20231214_Compensation Controls_NKG2A R660 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 52add04b6cda7b124ac83f3e93c19be4 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-12 | 20231214_Compensation Controls_NKG2D U730 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | be4c441ad393f09810d7f1c408e12b27 | 2023-12-14T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-13 | 20231221_Compensation Controls_CD103 B515 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | a251507c90dab5991647eb0e809b7bdb | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-14 | 20231221_Compensation Controls_CD107a V655 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 9973fd5dcf07a9127ce4e200b69d085c | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-15 | 20231221_Compensation Controls_CD158 G575 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | af305a68432252c8b1ee4a128dc89b78 | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-16 | 20231221_Compensation Controls_CD16 R780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | d341de15b51e1f6919a4fa4676b0252f | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-17 | 20231221_Compensation Controls_CD25 G780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | b947b87911c60afc58e2f26e4154cf61 | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-18 | 20231221_Compensation Controls_CD3 U395 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | d9de50fb79e2645844d4466797571dfa | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-19 | 20231221_Compensation Controls_CD57 G610 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 558934d277ec2aa8ad3afd1d4d4d77a6 | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-20 | 20231221_Compensation Controls_CD69 V780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 0e784ff92f5e0a8a33e830bc7ae0284b | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-21 | 20231221_Compensation Controls_CD8a B710 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 7c5d06a69f91169d724a746bf6290f74 | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-22 | 20231221_Compensation Controls_IFNg V450 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | bfdaa4415eac8c0c1329c9daa3c3188f | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-23 | 20231221_Compensation Controls_NKG2A R660 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | c60170eaf9f67fd3c913b08393a989ac | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-24 | 20231221_Compensation Controls_NKG2D U730 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | b39758ea8edfbf990cb5ca72ec653917 | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-25 | 20231221_Compensation Controls_Unstained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 1813af46fcac0ba3e1b1b7e7b7e425f7 | 2023-12-21T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-26 | 20240104_Compensation Controls_CD103 B515 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | d31f648104241fde615483cdfda84d11 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-27 | 20240104_Compensation Controls_CD107a V655 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 7d3579ed5b881f87abc8e029ec399e0d | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-28 | 20240104_Compensation Controls_CD158 G575 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 4e826a5b16cb82bf27aa25990b56f353 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-29 | 20240104_Compensation Controls_CD16 R780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | bff81d1de67d325ab48491a799983ae6 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-30 | 20240104_Compensation Controls_CD25 G780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | ea5bce4f3d46375aa4fae02b7e796fd9 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-31 | 20240104_Compensation Controls_CD3 U395 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 0875bca9e6be7e70cf321acfd444beff | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-32 | 20240104_Compensation Controls_CD57 G610 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 3d4e61c204148956c3f37b33d8c5e7a0 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-33 | 20240104_Compensation Controls_CD69 V780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 2a6dbfb51ed597b235e2158c0554bd4f | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-34 | 20240104_Compensation Controls_CD8a B710 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 43930ffdce4ab49f032e6e363cbfef43 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-35 | 20240104_Compensation Controls_IFNg V450 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 1c7c7f9a7b72427b067d697600e97dc0 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-36 | 20240104_Compensation Controls_NKG2A R660 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | b6356407c99cc7fdb3f3dce1461e34a1 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-37 | 20240104_Compensation Controls_NKG2D U730 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 4e7b52f5f3ff2bd75b395cd57b6f306b | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-38 | 20240104_Compensation Controls_Unstained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 67fc422ecd2f832e90a6ace7ba5b59a1 | 2024-01-04T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-39 | 20240118_Compensation Controls_CD103 B515 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 4b58bbba9eff3ddc80242094e5aa3cbb | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-40 | 20240118_Compensation Controls_CD107a V655 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 45d6f7ca4a61b0beb58f0773bd589f35 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-41 | 20240118_Compensation Controls_CD158 G575 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 007d063c63d6493f649c6734ae1955c6 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-42 | 20240118_Compensation Controls_CD16 R780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 963645a1bd1f32e0a17f66d467fff7ec | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-43 | 20240118_Compensation Controls_CD25 G780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 688a1f8de426d3a9a6085a219b5b59eb | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-44 | 20240118_Compensation Controls_CD3 U395 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 6c050a42fa367e57ed866491d1d05213 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-45 | 20240118_Compensation Controls_CD57 G610 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | ae7bbbd0797752a061e0ab3c797fcf36 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-46 | 20240118_Compensation Controls_CD69 V780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | e6250333a8a839dc050ad60771805796 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-47 | 20240118_Compensation Controls_CD8a B710 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 541eb602a8189673db34fb38a7cb3dd2 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-48 | 20240118_Compensation Controls_IFNg V450 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | dac420a6cbb942bfa1caf192f91b4444 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-49 | 20240118_Compensation Controls_NKG2A R660 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 41cb0832ebca08ecd1c6fc7f47c09fe3 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-50 | 20240118_Compensation Controls_NKG2D U730 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | f2f563c7b07564751bdf46bc871c5eca | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-51 | 20240118_Compensation Controls_Unstained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 10cc11a561124e641b3559085defe852 | 2024-01-18T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-52 | 20240125_Compensation Controls_CD103 B515 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | e1ac3870f9b2c44214acd1b805261e2e | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-53 | 20240125_Compensation Controls_CD107a V655 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 8fb57e86fba9dbd8873807faa27c2a28 | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-54 | 20240125_Compensation Controls_CD158 G575 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | d64fc4d036bce668f33cf6282e58c06f | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-55 | 20240125_Compensation Controls_CD16 R780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 90cf8eefbbcccd3c2f7fb69544117db3 | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-56 | 20240125_Compensation Controls_CD25 G780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 1e0b796375d2683889fb3a063af276d8 | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-57 | 20240125_Compensation Controls_CD3 U395 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | cc7eaf02d07a33828db05fec1f93aaaf | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-58 | 20240125_Compensation Controls_CD57 G610 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | ccd525e41541dbf2962162d5a09bde8f | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-59 | 20240125_Compensation Controls_CD69 V780 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | e2558297af392ce0a793a9d5d216e3c0 | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-60 | 20240125_Compensation Controls_CD8a B710 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 131296e7c08c552f606b7fa609f25a6f | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-61 | 20240125_Compensation Controls_IFNg V450 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 75dd4f7ef5f59f85e5a219c8e8d4eb8f | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-62 | 20240125_Compensation Controls_NKG2A R660 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 2d8f3e277bac609ed1efd8a30c788a16 | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-63 | 20240125_Compensation Controls_NKG2D U730 Stained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | cd68d4d83ca682ab5cdb7fd336bad59e | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
| D.FCS-250121SED-64 | 20240125_Compensation Controls_Unstained Control_001.fcs | https://www.immport.org/shared/study/SDY2942 | 2711be502e025cf44be63ec88b46ddc2 | 2024-01-25T0:0:0+0000 | Steven Makatsa | ABP-240826SED-1 | Compensation Files | https://fairdomhub.org/sops/812 | Immport | SDY2942 |
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
| UID | File_PrimaryData | Link_PrimaryData | Scientist | SampleCreationDate | Parent | Protocol | Type | CompensationFCSParent | AntibodyParent | Checksum_PrimaryData | Repository | Checksum_PrimaryType | RepositoryID | Stimulation | Software | Instrument | Fixation | Fixative |
| D.FLOW-240827SED-1 | SEDXX17_F1_F01_041.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-112 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | d8baf0ae30b20605d1336c4ef46f264e | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-2 | SEDXX17_F3_F03_043.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-204 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 7ab4293e96d8de5f6a80fdcfe1f14b83 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-3 | 20221_A1_A01_001.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-27 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | dbcb581803868fe1eb22ae045dcf32c3 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-4 | 20221_A3_A03_003.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-119 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | a7b0d99194e51e262f47b73daacc535c | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-5 | 20221_B1_B01_005.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-28 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | afbc94f1320463c9753e0dc3a6f12be2 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-6 | 20221_B3_B03_007.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-120 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 9701d9edefcdea9bb895d386eba5efe5 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-7 | 20221_C1_C01_009.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-29 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 892ccc2201f4665dff4609ceed4c71e5 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-8 | 20221_C3_C03_011.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-121 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | e2d3fe4a6f12728c0620e4023d9d7446 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-9 | 20221_D1_D01_013.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-30 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 46113a6353ee191fdb991a997b513226 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-10 | 20221_D3_D03_015.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-122 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 6e755f6491af15bca7f3fa12bb03eb4c | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-11 | 20221_E1_E01_017.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-31 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 604451e643b3335bfa00dd39b480000f | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-12 | 20221_E3_E03_019.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-123 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 7d051bcdf89ab2c1c12c94c09461018f | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-13 | 19521_A1_A01_002.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-32 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 6694a481f82e4c7c1d4c757e5730eecf | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-14 | 19521_A3_A03_004.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-124 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 09a78c8c0a85ba54f904ab850f43c507 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-15 | 19521_B1_B01_006.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-33 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 61a91b07800030729830cdfae06afc2f | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-16 | 19521_B3_B03_008.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-125 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | d646fc269b1214e2a42b5e64341d0af3 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-17 | 19521_BAL_A11_A11_028.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-34 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 0c50ba821d20640f8d1532fb650c46b5 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-18 | 19521_BAL_A9_A09_026.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-126 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 7bfcb68c1b964a259e31453383e05ade | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-19 | 19521_C1_C01_010.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-35 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | dff2f70241f1e65a16425272bb766fb9 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-20 | 19521_C3_C03_012.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-127 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | baea67ebcba8118d05aa0acfa25bb4d9 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-21 | SEDXX5_BAL_A11_A11_051.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-200 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 0710ba1bc00cdb3e2d1331cea03257a1 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-22 | SEDXX5_BAL_A9_A09_049.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-108 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 1d9c15a457b772ff05ca3125e2aabcc9 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-23 | SEDXX2_BAL_B11_B11_055.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-201 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 6bb7a7c093718905f5fd80f795360f24 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-24 | SEDXX2_BAL_B9_B09_053.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-109 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | e8ddcd1f0c6a515b8297ebe3d5810023 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-25 | SEDXX20_G1_G01_045.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-115 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 853129d76965bce4984238917fe4db11 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-26 | SEDXX20_G3_G03_047.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-207 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | ec39311904115f16e79d7e1f4a214d42 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-27 | 4519_BAL_B11_B11_032.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-147 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | b5f9e4f97db34f23d660f7e05b3a4b83 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-28 | 4519_BAL_B9_B09_030.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-55 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 1481874ad9c39b55f55b2931f17432ab | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-29 | 4519_D1_D01_046.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-52 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 8af44787249caaa7cd6e5a013b96bd89 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-30 | 4519_D3_D03_048.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-144 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 4dd6c00c118e8d5e2e59d03e41c3fe5c | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-31 | 4519_E1_E01_050.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240827SED-8 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 5a6d2c80842c0c0c774a084ce7ab50d2 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-32 | 4519_E3_E03_052.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240827SED-7 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | c5335a007453bd646082aff5835d97a7 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-33 | 4519_F1_F01_054.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-53 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | c6f6c42fe1966d9bfe52993aadc61df3 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-34 | 4519_F3_F03_056.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-145 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | bee4b55120c234939757745a1b017ad3 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-35 | 4519_G1_G01_058.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-54 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 98687912e21ae3f450774e31e208fb44 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-36 | 4519_G3_G03_060.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-146 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | f749d03e1237a947ba6c4708109421db | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-37 | 4219_A5_A05_021.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-153 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | e417b12dc138e9f32053bc434acd6828 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-38 | 4219_A7_A07_023.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-61 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | fffb9c8252c8ada26ac64eb1be4baf5e | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-39 | 4219_B5_B05_025.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-154 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 6d91fe30217651c2da41c333d39c6cb8 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-40 | 4219_B7_B07_027.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-62 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 2137f70a3cd613c05ae0a17fa4c772f8 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-41 | 4219_C5_C05_029.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-155 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 1c77296a591104a505cedbe198cc08d9 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-42 | 4219_C7_C07_031.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-63 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 32ccaae464d1b1dfb21bde2193357812 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-43 | 4219_D5_D05_033.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-156 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 19d764b62cd08aaba2af8a25359ff277 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-44 | 4219_D7_D07_035.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-64 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 015fcc7bf70469bd8ff93a44f1e2665f | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-45 | 4219_E5_E05_037.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-157 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 0a6c3d835840354eb473b92de2a3a45c | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-46 | 4219_E7_E07_039.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-65 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 4001ab33f67ff29e4478cb1d60e28166 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-47 | SEDXX15_BAL_D11_D11_063.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-202 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | ca39078887c7aad3315388749d0adbc9 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-48 | SEDXX15_BAL_D9_D09_061.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-110 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 2c397a2086f5f317b8679c5b3a3d64db | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-49 | SEDXX6_F5_F05_049.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-107 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 1fc5d21d80e811c773c6653e6175461a | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-50 | SEDXX6_F7_F07_051.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2023-12-14T0:0:0+0000 | TIS-240821SED-199 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-1; D.FCS-250121SED-2; D.FCS-250121SED-3; D.FCS-250121SED-4; D.FCS-250121SED-5; D.FCS-250121SED-6; D.FCS-250121SED-7; D.FCS-250121SED-8; D.FCS-250121SED-9; D.FCS-250121SED-10; D.FCS-250121SED-11; D.FCS-250121SED-12 | ABP-240826SED-1 | 263dfb3e5de1ca1a34483b483bcf46cd | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-51 | 21919_BAL_H5_H05_081.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-70 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | b70284550b6d87871036bb0f5c51cf74 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-52 | 21919_BAL_H7_H07_083.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-162 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 06c73d0aa57fbee2be93a5ea559faa3d | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-53 | 21919_E1_E01_017.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-66 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | a09c10b6a077a3b7af5f63b5420bf2f5 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-54 | 21919_E3_E03_019.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-158 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 1a15297c804f06f3bf1ad51f86e8533e | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-55 | 21919_F1_F01_021.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-67 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 2734de414d4ed5f63b6930cca57c80df | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-56 | 21919_F3_F03_023.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-159 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 3cf25b942d6c83d525bc07eec63d528a | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-57 | 21919_G1_G01_025.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-68 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 65500eef6bebb078f439fdf6a24363bd | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-58 | 21919_G3_G03_027.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-160 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 20283e0aa642afd395be358593f88486 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-59 | 21919_H1_H01_029.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-69 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 539929fc2602a6d26b6f91cde541d949 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-60 | 21919_H3_H03_031.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-161 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 6cd8d6cb7a6a36be067b50d4430cfc08 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-61 | 22619_A1_A01_001.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-71 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 05a72417feccc22fe4ae0c644f86e09b | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-62 | 22619_A3_A03_003.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-163 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 4a288334ce818aa454563069e79f8c5f | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-63 | 22619_B1_B01_005.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-72 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 90915127477169b2b9bdbbf1ed97ecc7 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-64 | 22619_B3_B03_007.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-164 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 3b23feb48604152c34e2455cd64b259b | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-65 | 22619_BAL_G5_G05_077.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-75 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | efb8956c71389fcb0cdf298566d1484f | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-66 | 22619_BAL_G7_G07_079.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-167 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 3192370f303b78ad9d1c0e41d5ebc0c3 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-67 | 22619_C1_C01_009.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-73 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | cac7cd4a15399425e8a47d023a46a154 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-68 | 22619_C3_C03_011.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-165 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | a553b888ec22ac9e801201b98acc37a9 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-69 | 22619_D1_D01_013.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-74 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | a7c00378bcb34494594dfc0cee1c4272 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-70 | 22619_D3_D03_015.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-166 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | 00283af97cca275a2613036ae23f6eec | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-71 | 21819_A5_A05_033.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-76 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 8e7184dca2f5468b3d412977d04154c9 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-72 | 21819_A7_A07_035.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-168 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 920b29ac99cd9c7f1326ff43b6f3a22b | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-73 | 21819_B5_B05_037.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-77 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 8d16362d3b2e9e43e6ca8e893b063419 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-74 | 21819_B7_B07_039.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-169 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 9efe0821738235015b5263c27b96db6a | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-75 | 21819_BAL_C11_C11_075.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-80 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 05d36e8ac1ab8cb675eafd07d232a3ab | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-76 | 21819_BAL_C9_C09_073.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-172 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 00458b43c5025ee9e5fb70f1501b4df7 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-77 | 21819_C5_C05_041.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-78 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 1e2cefd81a7125d42d7ed0178ab99aad | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-78 | 21819_C7_C07_043.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-170 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 70cc656a09ee1bd6113e70febc73c6c4 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-79 | 21819_D5_D05_045.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-79 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | f2e93d07c6b2a15660d47d7102f7b268 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-80 | 21819_D7_D07_047.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-171 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 27dc6470f00a4d8f7611f22673449055 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-81 | 21219_A5_A05_014.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-81 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | b52c9c7ef0f5d9d338bf175d8193b72d | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-82 | 21219_A7_A07_016.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-173 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | af69993ab83b0ce9e16e729781a2db94 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-83 | 21219_B5_B05_018.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-83 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 8cebba0c5590ef61f36ab12b9145a447 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-84 | 21219_B7_B07_020.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-175 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 3427c7b0c95df7516041ede36799ea26 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-85 | 21219_BAL_C11_C11_036.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-85 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | d1a90ba36a9827cfdaa7da00e92e9773 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-86 | 21219_BAL_C9_C09_034.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-177 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 557d36dfb2f6d1dec8c2e749eb261921 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-87 | 21219_C5_C05_022.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-84 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 761d13af080838993bfffa6c9fe214c1 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-88 | 21219_C7_C07_024.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-176 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 8c9a595c0ef09fb2f308401a2219fa3a | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-89 | SEDXX22_BAL_E11_E11_067.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-209 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | a7d1cc4bb091d040fed7ecbc63b9c008 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-90 | SEDXX22_BAL_E9_E09_065.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-117 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | de1c55a8ba7eb7320fdb4e8316ddfbb5 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-91 | SEDXX19_BAL_E11_E11_044.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-206 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | 8c98b76a51bfd414d8b56e4746b4e1ca | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-92 | SEDXX19_BAL_E9_E09_042.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-18T0:0:0+0000 | TIS-240821SED-114 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-39; D.FCS-250121SED-40; D.FCS-250121SED-41; D.FCS-250121SED-42; D.FCS-250121SED-43; D.FCS-250121SED-44; D.FCS-250121SED-45; D.FCS-250121SED-46; D.FCS-250121SED-47; D.FCS-250121SED-48; D.FCS-250121SED-49; D.FCS-250121SED-50; D.FCS-250121SED-51 | ABP-240826SED-1 | c4a892ec0efc88461b2fbb38d8e1c0c8 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-93 | SEDXX23_BAL_F11_F11_087.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-210 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | ab0df9d3b2afbcca1b98d021ef84f880 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-94 | SEDXX23_BAL_F9_F09_085.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-25T0:0:0+0000 | TIS-240821SED-118 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-52; D.FCS-250121SED-53; D.FCS-250121SED-54; D.FCS-250121SED-55; D.FCS-250121SED-56; D.FCS-250121SED-57; D.FCS-250121SED-58; D.FCS-250121SED-59; D.FCS-250121SED-60; D.FCS-250121SED-61; D.FCS-250121SED-62; D.FCS-250121SED-63; D.FCS-250121SED-64 | ABP-240826SED-1 | ab75b7f4802974e87ba54e56f51d9494 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-95 | 21519_BAL_B11_B11_071.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-182 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 5388376847cddd591f537c02bbe54e23 | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-96 | 21519_BAL_B9_B09_069.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-90 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | d2437a94f7584321a606c93e12f532b6 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-97 | 21519_E1_E01_017.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-86 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 4b698bff84c04dfcd53ae6a1496cc931 | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-98 | 21519_E3_E03_019.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-178 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 2085caffe910d95353f3a87fea06139c | ImmPort | MD5 | SDY2942 | Mtb Lysate | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
| D.FLOW-240827SED-99 | 21519_F1_F01_021.fcs | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | 2024-01-04T0:0:0+0000 | TIS-240821SED-87 | https://fairdomhub.org/sops/812 | Flow Cytometry | D.FCS-250121SED-26; D.FCS-250121SED-27; D.FCS-250121SED-28; D.FCS-250121SED-29; D.FCS-250121SED-30; D.FCS-250121SED-31; D.FCS-250121SED-32; D.FCS-250121SED-33; D.FCS-250121SED-34; D.FCS-250121SED-35; D.FCS-250121SED-36; D.FCS-250121SED-37; D.FCS-250121SED-38 | ABP-240826SED-1 | 62fd1f5e5a636da5ba79382617e770da | ImmPort | MD5 | SDY2942 | Unstimulated | FlowJo | BD LSRFortessa | Yes | 1% Paraformaldehyde |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | File_PrimaryData | Link_PrimaryData | Checksum_PrimaryData | Scientist | Parent | Protocol | Software | Checksum_PrimaryType | |
| A.FLOW-241212SED-1 | FACS FlowJo analysis.wsp | https://www.immport.org/shared/study/SDY2942 | 4d40ba52dd7645ff2562ada7e5ffc465 | Steven Makatsa | D.FLOW-240827SED-1; D.FLOW-240827SED-2; D.FLOW-240827SED-3; D.FLOW-240827SED-4; D.FLOW-240827SED-5; D.FLOW-240827SED-6; D.FLOW-240827SED-7; D.FLOW-240827SED-8; D.FLOW-240827SED-9; D.FLOW-240827SED-10; D.FLOW-240827SED-11; D.FLOW-240827SED-12; D.FLOW-240827SED-13; D.FLOW-240827SED-14; D.FLOW-240827SED-15; D.FLOW-240827SED-16; D.FLOW-240827SED-17; D.FLOW-240827SED-18; D.FLOW-240827SED-19; D.FLOW-240827SED-20; D.FLOW-240827SED-21; D.FLOW-240827SED-22; D.FLOW-240827SED-23; D.FLOW-240827SED-24; D.FLOW-240827SED-25; D.FLOW-240827SED-26; D.FLOW-240827SED-27; D.FLOW-240827SED-28; D.FLOW-240827SED-29; D.FLOW-240827SED-30; D.FLOW-240827SED-31; D.FLOW-240827SED-32; D.FLOW-240827SED-33; D.FLOW-240827SED-34; D.FLOW-240827SED-35; D.FLOW-240827SED-36; D.FLOW-240827SED-37; D.FLOW-240827SED-38; D.FLOW-240827SED-39; D.FLOW-240827SED-40; D.FLOW-240827SED-41; D.FLOW-240827SED-42; D.FLOW-240827SED-43; D.FLOW-240827SED-44; D.FLOW-240827SED-45; D.FLOW-240827SED-46; D.FLOW-240827SED-47; D.FLOW-240827SED-48; D.FLOW-240827SED-49; D.FLOW-240827SED-50; D.FLOW-240827SED-51; D.FLOW-240827SED-52; D.FLOW-240827SED-53; D.FLOW-240827SED-54; D.FLOW-240827SED-55; D.FLOW-240827SED-56; D.FLOW-240827SED-57; D.FLOW-240827SED-58; D.FLOW-240827SED-59; D.FLOW-240827SED-60; D.FLOW-240827SED-61; D.FLOW-240827SED-62; D.FLOW-240827SED-63; D.FLOW-240827SED-64; D.FLOW-240827SED-65; D.FLOW-240827SED-66; D.FLOW-240827SED-67; D.FLOW-240827SED-68; D.FLOW-240827SED-69; D.FLOW-240827SED-70; D.FLOW-240827SED-71; D.FLOW-240827SED-72; D.FLOW-240827SED-73; D.FLOW-240827SED-74; D.FLOW-240827SED-75; D.FLOW-240827SED-76; D.FLOW-240827SED-77; D.FLOW-240827SED-78; D.FLOW-240827SED-79; D.FLOW-240827SED-80; D.FLOW-240827SED-81; D.FLOW-240827SED-82; D.FLOW-240827SED-83; D.FLOW-240827SED-84; D.FLOW-240827SED-85; D.FLOW-240827SED-86; D.FLOW-240827SED-87; D.FLOW-240827SED-88; D.FLOW-240827SED-89; D.FLOW-240827SED-90; D.FLOW-240827SED-91; D.FLOW-240827SED-92; D.FLOW-240827SED-93; D.FLOW-240827SED-94; D.FLOW-240827SED-95; D.FLOW-240827SED-96; D.FLOW-240827SED-97; D.FLOW-240827SED-98; D.FLOW-240827SED-99; D.FLOW-240827SED-100; D.FLOW-240827SED-101; D.FLOW-240827SED-102; D.FLOW-240827SED-103; D.FLOW-240827SED-104; D.FLOW-240827SED-105; D.FLOW-240827SED-106; D.FLOW-240827SED-107; D.FLOW-240827SED-108; D.FLOW-240827SED-109; D.FLOW-240827SED-110; D.FLOW-240827SED-111; D.FLOW-240827SED-112; D.FLOW-240827SED-113; D.FLOW-240827SED-114; D.FLOW-240827SED-115; D.FLOW-240827SED-116; D.FLOW-240827SED-117; D.FLOW-240827SED-118; D.FLOW-240827SED-119; D.FLOW-240827SED-120; D.FLOW-240827SED-121; D.FLOW-240827SED-122; D.FLOW-240827SED-123; D.FLOW-240827SED-124; D.FLOW-240827SED-125; D.FLOW-240827SED-126; D.FLOW-240827SED-127; D.FLOW-240827SED-128; D.FLOW-240827SED-129; D.FLOW-240827SED-130; D.FLOW-240827SED-131; D.FLOW-240827SED-132; D.FLOW-240827SED-133; D.FLOW-240827SED-134; D.FLOW-240827SED-135; D.FLOW-240827SED-136; D.FLOW-240827SED-137; D.FLOW-240827SED-138; D.FLOW-240827SED-139; D.FLOW-240827SED-140; D.FLOW-240827SED-141; D.FLOW-240827SED-142; D.FLOW-240827SED-143; D.FLOW-240827SED-144; D.FLOW-240827SED-145; D.FLOW-240827SED-146; D.FLOW-240827SED-147; D.FLOW-240827SED-148; D.FLOW-240827SED-149; D.FLOW-240827SED-150 | https://fairdomhub.org/sops/812 | FlowJo | MD5 | |
A
B
C
D
E
F
G
H
I
J
K
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | File_PrimaryData | Scientist | Link_PrimaryData | Instrument | SampleCreationDate | Parent | Stimulation | Protocol | Checksum_PrimaryData | AntibodyPanelParent |
| D.CYTOF-240827SED-1 | SEDXX10_MtbL_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-22 | Mtb Lysate | https://fairdomhub.org/sops/813 | 29e9f68e25452bcadabc499c86cee968 | ABP-241212SED-1 |
| D.CYTOF-240827SED-2 | SEDXX10_NS_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-17 | Unstimulated | https://fairdomhub.org/sops/813 | dc0183ffc27903db1dc4396d8527bd73 | ABP-241212SED-1 |
| D.CYTOF-240827SED-3 | SEDXX11_MtbL_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-23 | Mtb Lysate | https://fairdomhub.org/sops/813 | 8e7cbe725515de1f1d93073e4380d2ca | ABP-241212SED-1 |
| D.CYTOF-240827SED-4 | SEDXX11_NS_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-18 | Unstimulated | https://fairdomhub.org/sops/813 | 0163f9a4072d9b2b61f14dd1a18ee9d8 | ABP-241212SED-1 |
| D.CYTOF-240827SED-5 | SEDXX5_BAL_wk4_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-200 | Mtb Lysate | https://fairdomhub.org/sops/813 | 0283204d3ec8c31e4c553bb0d6fdb01e | ABP-241212SED-1 |
| D.CYTOF-240827SED-6 | SEDXX5_BAL_wk4_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-108 | Unstimulated | https://fairdomhub.org/sops/813 | 600fb8107d6f23fa40e747d3bb572427 | ABP-241212SED-1 |
| D.CYTOF-240827SED-7 | SEDXX5_BAL_wk8_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240827SED-1 | Mtb Lysate | https://fairdomhub.org/sops/813 | 0301f0039b002b933d548c94f8ad83da | ABP-241212SED-1 |
| D.CYTOF-240827SED-8 | SEDXX5_BAL_wk8_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240827SED-2 | Unstimulated | https://fairdomhub.org/sops/813 | 16dddc750a1e0aea5539e0a9443ea430 | ABP-241212SED-1 |
| D.CYTOF-240827SED-9 | SEDXX8 BAL wk 4 Mtb_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-11 | Mtb Lysate | https://fairdomhub.org/sops/813 | ae030f43733fd45bf15f35572b2589b0 | ABP-241212SED-1 |
| D.CYTOF-240827SED-10 | SEDXX8 BAL wk 4 NS_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-3 | Unstimulated | https://fairdomhub.org/sops/813 | fced0e40151cf882cdb73acfccf63d42 | ABP-241212SED-1 |
| D.CYTOF-240827SED-11 | SEDXX1 BAL wk 4 Mtb_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-15 | Mtb Lysate | https://fairdomhub.org/sops/813 | 2caada52fa18cfb2a5efb2bb6742ad88 | ABP-241212SED-1 |
| D.CYTOF-240827SED-12 | SEDXX1 BAL wk 4 NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-7 | Unstimulated | https://fairdomhub.org/sops/813 | ecb56b58bb2c1dc28615d013fe4546c1 | ABP-241212SED-1 |
| D.CYTOF-240827SED-13 | SEDXX2_BAL_4wk_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-201 | Mtb Lysate | https://fairdomhub.org/sops/813 | d1917bba9959e235e6da96742619e783 | ABP-241212SED-1 |
| D.CYTOF-240827SED-14 | SEDXX2_BAL_4wk_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-109 | Unstimulated | https://fairdomhub.org/sops/813 | a29a4ce7a2c7f2b8f21c7bee2315e3b5 | ABP-241212SED-1 |
| D.CYTOF-240827SED-15 | SEDXX2_BAL_8wk_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240827SED-3 | Mtb Lysate | https://fairdomhub.org/sops/813 | f82788a4e763c8f4b8053c0fb5ebfd59 | ABP-241212SED-1 |
| D.CYTOF-240827SED-16 | SEDXX2_BAL_8wk_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240827SED-4 | Unstimulated | https://fairdomhub.org/sops/813 | 204b7b31a43c368003168c88398d9239 | ABP-241212SED-1 |
| D.CYTOF-240827SED-17 | SEDXX6_BAL_4wk_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-199 | Mtb Lysate | https://fairdomhub.org/sops/813 | c3200f5b2725b10fe4c4e79ac510725e | ABP-241212SED-1 |
| D.CYTOF-240827SED-18 | SEDXX6_BAL_4wk_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-107 | Unstimulated | https://fairdomhub.org/sops/813 | df3236207a8fb4871c9ee8eb74ff907d | ABP-241212SED-1 |
| D.CYTOF-240827SED-19 | SEDXX6_BAL_8wk_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240827SED-5 | Mtb Lysate | https://fairdomhub.org/sops/813 | 8ace8d41fea50af3a0c50aca2b03cb43 | ABP-241212SED-1 |
| D.CYTOF-240827SED-20 | SEDXX6_BAL_8wk_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240827SED-6 | Unstimulated | https://fairdomhub.org/sops/813 | a7c9570e556c557a0b5db7831a263eb5 | ABP-241212SED-1 |
| D.CYTOF-240827SED-21 | SEDXX7_BAL_4wk_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-221024SED-37 | Mtb Lysate | https://fairdomhub.org/sops/813 | 7782ead4704749250698206b497c93ae | ABP-241212SED-1 |
| D.CYTOF-240827SED-22 | SEDXX7_BAL_4wk_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-221024SED-17 | Unstimulated | https://fairdomhub.org/sops/813 | 05e11e742af8db0d807a409cec3065fd | ABP-241212SED-1 |
| D.CYTOF-240827SED-23 | SEDXX7_BAL_8wk_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-221024SED-39 | Mtb Lysate | https://fairdomhub.org/sops/813 | 08b7cddb2219c3521c3633a72c11c207 | ABP-241212SED-1 |
| D.CYTOF-240827SED-24 | SEDXX7_BAL_8wk_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-221024SED-19 | Unstimulated | https://fairdomhub.org/sops/813 | 95e9dc9b54dfc9cbe74501224f40744c | ABP-241212SED-1 |
| D.CYTOF-240827SED-25 | SEDXX13_MtbL_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-20 | Mtb Lysate | https://fairdomhub.org/sops/813 | 376f15ae9bfed9f1c37bc302d19ca160 | ABP-241212SED-1 |
| D.CYTOF-240827SED-26 | SEDXX13_NS_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-25 | Unstimulated | https://fairdomhub.org/sops/813 | b3fbfcaedadc3b61c492c4082ab19e2e | ABP-241212SED-1 |
| D.CYTOF-240827SED-27 | SEDXX14_MtbL_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-26 | Mtb Lysate | https://fairdomhub.org/sops/813 | 285fa62a01e022443daaf8e76d2789f1 | ABP-241212SED-1 |
| D.CYTOF-240827SED-28 | SEDXX14_NS_02_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-21 | Unstimulated | https://fairdomhub.org/sops/813 | ee64efc7c2a198e4105cda7454a9fc6d | ABP-241212SED-1 |
| D.CYTOF-240827SED-29 | SEDXX12_MtbL_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-208 | Mtb Lysate | https://fairdomhub.org/sops/813 | 44acb6a8f655f10687597d0be6872ab7 | ABP-241212SED-1 |
| D.CYTOF-240827SED-30 | SEDXX12_NS_01_1.fcs | Steven Makatsa | https://www.immport.org/shared/study/SDY2942 | Helios (Standard Biotools) | 2024-07-16T0:0:0+0000 | TIS-240821SED-116 | Unstimulated | https://fairdomhub.org/sops/813 | 9654992a4288cfeb2764e12063ccb7b3 | ABP-241212SED-1 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | File_PrimaryData | Link_PrimaryData | Scientist | Parent | Protocol | Software | Checksum_PrimaryData | Checksum_PrimaryType | |
| A.CYTOF-241212SED-1 | CyTOF FlowJo analysis.wsp | https://www.immport.org/shared/study/SDY2942 | Steven Makatsa | D.CYTOF-240827SED-1; D.CYTOF-240827SED-2; D.CYTOF-240827SED-3; D.CYTOF-240827SED-4; D.CYTOF-240827SED-5; D.CYTOF-240827SED-6; D.CYTOF-240827SED-7; D.CYTOF-240827SED-8; D.CYTOF-240827SED-9; D.CYTOF-240827SED-10; D.CYTOF-240827SED-11; D.CYTOF-240827SED-12; D.CYTOF-240827SED-13; D.CYTOF-240827SED-14; D.CYTOF-240827SED-15; D.CYTOF-240827SED-16; D.CYTOF-240827SED-17; D.CYTOF-240827SED-18; D.CYTOF-240827SED-19; D.CYTOF-240827SED-20; D.CYTOF-240827SED-21; D.CYTOF-240827SED-22; D.CYTOF-240827SED-23; D.CYTOF-240827SED-24; D.CYTOF-240827SED-25; D.CYTOF-240827SED-26; D.CYTOF-240827SED-27; D.CYTOF-240827SED-28; D.CYTOF-240827SED-29; D.CYTOF-240827SED-30 | https://fairdomhub.org/sops/813 | FlowJo | b7327b014ae289a0745f306e8d06a7ed | MD5 | |
